We want to reward active particpants in the ENS community ๐
& stress test our new marketplace functionality
So we're having a competition running through September
List the most names - win a premium name ๐ค
Spend the most on names - win a premium name ๐ฐ
Choose 1 from here
We want to reward active particpants in the ENS community ๐
& stress test our new marketplace functionality
So we're having a competition running through September
List the most names - win a premium name ๐ค
Spend the most on names - win a premium name ๐ฐ
Choose 1 from here
Cannot wait for our NIOME (Client) Summit on June 4th ๐งฌ
For those of you interested to hear more about who will be attending, have a listen to this recorded Space! ๐๏ธ
A NIOME future is now. Join us! ๐
https://t.co/KrTir04EHs
Loved putting together that overview of @NiomeAI
(SN55) and the community is responding!
But How NIOME (@NiomeAI) Bittensor Subnet 55 actually works and why itโs positioned to lead the programmable biology revolution How it works:
- Miners run advanced AI models to generate high-fidelity synthetic human genomes statistically identical to real DNA in allele frequencies, linkage patterns, and biological behaviors, but with zero privacy risk.
- Validators create challenge tasks (e.g., population simulations, noisy reads, phenotype predictions) and score miners on statistical accuracy + biological plausibility.
The best outputs win emissions through Bittensorโs incentive mechanism creating a self-improving marketplace for unlimited, ethical genomic data.
No real patient DNA is ever used. Just realistic, scalable synthetic data for pharma, drug discovery, and precision medicine.
Future plans to stay on top (as earlier said):
โ Roadmap 1.1 is now LIVE CFTR genotype inference active, miners recovering real variants from synthetic reads, and daily competitions where Top 10 miners take 100% emissions
โ Just wrapped an incredible appearance at the DCG/Yuma Summit shared highlights in a recent Space with the Bittensor OGs
โ Expanding partnership with @aberdeenuniโs Institute of Medical Sciences is deepening
$150K AWS grant powering infrastructure growth
A NIOME future is now ๐. If youโre in biotech, research, or Bittensor, this is one to follow closely...๐
Real progress. Real science. Real decentralized future.
If you missed the first post, check it out and follow @NiomeAI for live updates on SN55...
๐ฌ๐ง JUST IN: Coinbase has listed GBP-backed stablecoin tGBP globally, expanding access to local currency stablecoins and pushing UK crypto adoption.
Pharma & biotech are sitting on a genomic data crisis โ siloed, insecure, unscalable.
@NiomeAI (SN55 on #Bittensor) is fixing this at the infrastructure level: a decentralised bio-data subnet that generates
-validates
-improves genomic data through incentive-driven networks
-built for AI-driven drug discovery at scale.
This is what real DeSci looks like. ๐งฌ
@Bitcast_network@bittensor
#TAO #Bittensor
Decentralised genomics for AI-driven drug discovery is here and @NiomeAI SN55 on Bittensor $TAO is building it.
Pharma & research need genomic data that is precise, private and at scale. NIOME solves all three through decentralised infrastructure that generates, validates and continuously improves bio data.
Built on https://t.co/X2mElUaICw's privacy-first foundation with thousands of users already. Backed by Scottish Enterprise & University of Aberdeen.
24 Predictive Challenges across 6 Genomics Research Fields Challenge 1.1 is live now: Cystic Fibrosis (CFTR).
This is decentralised science. This is what $TAO was built for ๐งฌโก
Excited to spotlight NIOME @NiomeAI... a true gamechanger in programmable biology!
NIOME is Bittensor Subnet 55, building the decentralized intelligence layer for life sciences.
From the team behind https://t.co/PAWdmfAtzJ, They create high-fidelity, Privacy-safe synthetic human genomes that are statistically indistinguishable from real DNA at unlimited scale. No more ethical or legal barriers holding back pharma and research.
NIOME delivers the massive,
- Secure genomic datasets needed for faster drug discovery,
- Precision medicine,
- Progressive disease modeling, and beyond.
Weโre already seeing real momentum: expanding partnerships (including a deeper collaboration with the Institute of Medical Sciences at @aberdeenuni), a $150K AWS grant to scale synthetic omics infrastructure, growing validator & miner activity, and client pipelines driving us toward $500K ARR this year.
Next up? Roadmap 1.1 with enhanced scoring for
- Biological accuracy,
- Microbiome research initiatives,
- More real-world bio-data applications, and even stronger integration of decentralized AI into everyday genomic intelligence.
A NIOME future is now safer, more scalable, and truly decentralized. If youโre in pharma, research, or the Bittensor ecosystem, this is one to watch closely...
At NIOME, we put our clients first.
We understand that safely sourced, high-quality genomic data is essential to driving innovation.๐งฌ
Thatโs where NIOME delivers, providing large-scale, precise synthetic genomic data you can trust. ๐ก๏ธ
Built on safety. Driven by precision. Designed to scale.
A $TAO future is now. Join us!
https://t.co/qUZfF6By6b
We had quite a busy week last week further building NIOME - have a listen to the recording of our weekly AMA to find out more. ๐๏ธ ๐งฌ
Lots of work to be done. Onwards!๐ช
If you are looking for a a no-jargon walkthrough for buying NIOME, https://t.co/4G3ODbHgx3โs Bittensor subnet token
Here it is
https://t.co/mPpPuisprc
Also here: https://t.co/SFujvsXAXV